FDA Approves Levetiracetam in Sodium Chloride by Mylan Labs
The FDA has approved the application ANDA218364 for levetiracetam in sodium chloride submitted by Mylan Labs.
Company
Pharmaceutical intelligence for Mylan Labs with 6 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No signals indexed for this entity yet.
No signals indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.